0000000000668637

AUTHOR

Ioannis Drosos

0000-0002-7437-8896

showing 4 related works from this author

Do urocortins have a role in treating cardiovascular disease?

2018

Corticotropin-releasing factor (CRF) and the three homolog neuropeptides, urocortin (UCN) 1, 2 and 3, are the major neuroendocrine factors implicated in the response of the body to stress. Recent evidence suggests that UCNs have a significant role in the pathogenesis and management of cardiovascular disease, such as congestive heart failure, ischemic heart disease, and hypertension. These data led to the initiation of clinical trials testing a possible role of UCNs in the diagnosis and therapy of cardiovascular disease, with encouraging results. Here, we summarize the available literature concerning the role of UCNs in the cardiovascular system, focusing on the emerging data creating a pote…

0301 basic medicineendocrine systemCorticotropin-Releasing HormoneDiseaseBioinformaticsCardiovascular SystemPathogenesis03 medical and health sciences0302 clinical medicineDrug Discoveryotorhinolaryngologic diseasesMedicineAnimalsHumansUrocortinsPharmacologyUrocortinbusiness.industrymedicine.diseaseClinical trial030104 developmental biologyCardiovascular Diseases030220 oncology & carcinogenesisHeart failurebusinessIschemic heartUrocortinsDrug discovery today
researchProduct

TNF-α blockade may lead to improvement of vascular function in psoriasis patients.

2021

Psoriasis is one of the most common chronic inflammatory skin diseases and at the same time a risk factor for cardiovascular disease. Interleukin-17A (IL-17A)-mediated inflammation in psoriasis may lead to vascular dysfunction. This study aimed at investigating whether anti-inflammatory treatment by tumor necrosis factor (TNF)-α blockade alters vascular function in psoriasis patients. A total of 11 patients with psoriasis who underwent treatment with either adalimumab (n = 8) or etanercept (n = 3), 10 healthy control individuals and 14 patients with coronary artery disease (CAD) were included in this study. Treatment response was assessed using the Psoriasis Area and Severity Index (PASI) s…

medicine.medical_specialtyDermatologyBiochemistryGastroenterologyEtanerceptCoronary artery diseasePsoriasis Area and Severity IndexInternal medicinePsoriasismedicineAdalimumabHumansPsoriasisRisk factorMolecular Biologybusiness.industryTumor Necrosis Factor-alphamedicine.diseaseBlockadeVasodilationVasoconstrictionChronic DiseaseTumor necrosis factor alphaTumor Necrosis Factor InhibitorsEndothelium Vascularbusinessmedicine.drugExperimental dermatologyREFERENCES
researchProduct

Lysed Erythrocyte Membranes Promote Vascular Calcification

2019

Background: Intraplaque hemorrhage promotes atherosclerosis progression, and erythrocytes may contribute to this process. In this study we examined the effects of red blood cells on smooth muscle cell mineralization and vascular calcification and the possible mechanisms involved. Methods: Erythrocytes were isolated from human and murine whole blood. Intact and lysed erythrocytes and their membrane fraction or specific erythrocyte components were examined in vitro using diverse calcification assays, ex vivo by using the murine aortic ring calcification model, and in vivo after murine erythrocyte membrane injection into neointimal lesions of hypercholesterolemic apolipoprotein E–deficient mi…

0303 health sciencesLysisbusiness.industrySmooth muscle myocytes030204 cardiovascular system & hematologyCell biology03 medical and health sciences0302 clinical medicineMembraneSmooth musclePhysiology (medical)MedicineCardiology and Cardiovascular MedicinebusinessVascular calcificationProcess (anatomy)030304 developmental biologyCirculation
researchProduct

Increased Lymphangiogenesis and Lymphangiogenic Growth Factor Expression in Perivascular Adipose Tissue of Patients with Coronary Artery Disease

2019

Experimental and human autopsy studies have associated adventitial lymphangiogenesis with atherosclerosis. An analysis of perivascular lymphangiogenesis in patients with coronary artery disease is lacking. Here, we examined lymphangiogenesis and its potential regulators in perivascular adipose tissue (PVAT) surrounding the heart (C-PVAT) and compared it with PVAT of the internal mammary artery (IMA-PVAT). Forty-six patients undergoing coronary artery bypass graft surgery were included. Perioperatively collected C-PVAT and IMA-PVAT were analyzed using histology, immunohistochemistry, real time PCR, and PVAT-conditioned medium using cytokine arrays. C-PVAT exhibited increased PECAM-1 (platele…

Pathologymedicine.medical_specialtymedicine.medical_treatmentgovernment.form_of_governmentlcsh:MedicineAdipose tissue030204 cardiovascular system & hematologyArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrosisperivascular adipose tissuemedicineLymphatic vesselhuman030304 developmental biology0303 health sciencesbusiness.industrylcsh:Rcoronary artery disease; human; inflammation; lymphangiogenesis; perivascular adipose tissueGeneral Medicinemedicine.diseaseLymphangiogenesislymphangiogenesisVascular endothelial growth factorLymphatic EndotheliumCytokinemedicine.anatomical_structureLymphatic systemchemistryinflammationgovernmentbusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct